I think that's why we have seen shorts take defensive measures by buying options and what not. Volume is so little they can't get out, announcement of trial start we could shoot up to 10 easily, it's more risky to short than be long. The potential share price if all goes well is way north of here. 25 dollars is around a one billion market cap. The short squeeze could make it run higher on trial news or data from a trial. I personally don't think we will get the exact start date. People will have to look on the FDA website to see, by then it'll already be week one-four.
If everything goes well and the drug is approved and replaces standard of care we could be over $100 in a heartbeat.
News 
Market Data 
Discover 
AI
